.png)
Queer Progress in Medicine
Barriers in Medicine?
Historically, LGBTQ+ individuals have encountered numerous barriers to accessing adequate healthcare due to pervasive stigma, discrimination, and a lack of understanding from medical professionals. For many years, homosexuality was pathologized, leading to harmful practices like conversion therapy and contributing to widespread fear and mistrust of the medical system among LGBTQ+ people. These barriers have resulted in significant health disparities, with LGBTQ+ individuals often receiving inadequate care or avoiding healthcare settings altogether due to fear of discrimination. This legacy has had a lasting impact on the health and well-being of the LGBTQ+ community.
Despite queer progress in medicine, a multitude of barriers and blatant discrimination exist for LGBTQ individuals in America and beyond. HealthPride was founded based on this concept and will continue to fight for inclusive medical environemnts and health treatment.
1952
Introduction of Hormone Therapy
Christine Jorgensen became one of the first Americans to undergo gender-affirming surgery, which included hormone therapy, bringing attention to transgender medical care.
1973
Declassification of Homosexuality as a Mental Disorder
The American Psychiatric Association removed homosexuality from the DSM-II, marking a significant reduction in stigma associated with LGBTQ+ identities.
1981
First Recognition of HIV/AIDS
The CDC reported the first cases of what would later be known as AIDS, leading to focused research and advocacy within the LGBTQ+ community.
1987
Formation of the National Gay and Lesbian Task Force’s AIDS Initiative
This initiative was crucial in advocating for LGBTQ+ individuals affected by the AIDS epidemic, pushing for better healthcare responses.
1994
Introduction of WPATH’s Standards of Care for Transgender Health
The World Professional Association for Transgender Health published its first version of the Standards of Care, setting guidelines for gender-affirming healthcare.
1996
Introduction of Protease Inhibitors for HIV
The FDA approved the first protease inhibitors, revolutionizing HIV treatment and reducing mortality rates, particularly benefiting gay and bisexual men.
2012
FDA Approval of PrEP (Pre-Exposure Prophylaxis) for HIV Prevention
Truvada was approved for reducing the risk of HIV infection, especially significant for at-risk LGBTQ+ populations. This approval would lead to other protective medications such as PEP and DoxyPEP being commercialized.
2015
Same-Sex Marriage Healthcare Benefits
The Supreme Court’s decision in Obergefell v. Hodges legalized same-sex marriage nationwide, improving access to spousal healthcare benefits.
2015
FDA Drops Blood-Donation Ban on Gay Men
In 2015, the FDA made a significant policy change by easing the lifetime ban on blood donations from gay and bisexual men, which had been in place since the 1980s at the height of the HIV/AIDS crisis.
2020
Supreme Court Rules LGBTQ+ Discrimination in Employment Illegal
The ruling in Bostock v. Clayton County extended protections under Title VII of the Civil Rights Act to LGBTQ+ individuals, influencing non-discrimination in healthcare as well.
(Continual)
General Global Progress
Globally, progress in LGBTQ+ healthcare has been marked by increasing access to gender-affirming care and greater legal protections against discrimination in several countries. These efforts reflect a growing international commitment to ensuring that LGBTQ+ individuals receive equitable and respectful healthcare services.